Impact of Race on Clinical Outcomes in IBD Patients on Anti-TNF Monotherapy and Anti-TNF Combination Therapy With Immunomodulators: A Propensity-Matched Cohort Study

被引：0
|
作者：
Nawaz, Ahmad [1 ]
Almasaid, Sharifeh [1 ]
Shah, Ayushi [1 ]
Hussain, Azhar [1 ]
Chaar, Abdelkader [1 ]
Patel, Shanti [2 ]
Khalid, Fatima [3 ]
Hayat, Umar [4 ]
Singh, Kelita [1 ]
Aswath, Ganesh [1 ]
Khan, Hafiz Muzaffar Akbar [1 ]
机构：
[1] SUNY Syracuse, Upstate Med Univ, Syracuse, NY USA
[2] Yale New Haven Hosp, New Haven, CT USA
[3] Fatima Mem Hosp, Lahore, Punjab, Pakistan
[4] Geisinger Wyoming Valley Med Ctr, Wilkes Barre, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001035020.13797.dd
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1413
引用
收藏
页码：S1011 / S1012
页数：2
相关论文
共 50 条
  • [41] Clinical utility of anti-IFI16 seroreactivity in the response to anti-TNF therapy in IBD
    Caneparo, V.
    Verstockt, B.
    Vermeire, S.
    Landolfo, S.
    Gariglio, M.
    De Andrea, M.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S412 - S412
  • [42] Outcomes in IBD Patients Who Are Exposed to a Subsequent Anti-TNF Agent Following Anti-TNF Drug Induced Lupus-Like Reaction
    Venu, Mukund
    Dodda, Amar
    Gonzaga, Jason E.
    Naik, Amar S.
    Venu, Nanda
    Perera, Lilani P.
    Stein, Daniel
    GASTROENTEROLOGY, 2013, 144 (05) : S409 - S409
  • [43] Impact of Race on ANTI-TNF Immunogenicity in Patients with Inflammatory Bowel Disease
    Nawaz, Ahmad
    Chaar, Abdelkader
    Li, Darrick K.
    Gaidos, Jill K.
    Proctor, Deborah
    Al-Bawardy, Badr
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10) : S623 - S624
  • [44] IMNUNOGENICITY AND CLINICAL PRACTICE IN PATIENTS TREATED WITH ANTI-TNF THERAPY
    Alcocer, P.
    Plasencia, C.
    Pascual, D.
    Garcia Carazo, S.
    Franco, K. N.
    Cagijas, D.
    Lojo, L.
    Bonilla, G.
    Nuno, L.
    Villalba, A.
    Lopez Casla, M. T.
    Balsa, A.
    Martin Mola, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 871 - 872
  • [45] Tuberculosis in patients on anti-TNF therapy in Turkey
    Akkoc, N.
    Sari, I.
    Akar, S.
    Birlik, M.
    Capar, S.
    Onen, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 499 - 500
  • [46] VEDOLIZUMAB INDUCED ENDOSCOPIC REMISSION IN ANTI-TNF NAIVE AND ANTI-TNF EXPOSED IBD PATIENTS: A LARGE SINGLE CENTRE EXPERIENCE
    Verstockt, Bram
    Mertens, Evelien
    Outtier, An
    Van Assche, Gert A.
    Vermeire, Severine
    Ferrante, Marc
    GASTROENTEROLOGY, 2019, 156 (06) : S877 - S878
  • [47] HRQOL Measures In IBD Patients Receiving Prolonged Treatment with Anti-TNF Therapy
    Yoon, Sonia
    DeCross, Arthur
    Shah, Ashok
    St Hilaire, Lydia
    Sherman, Michael
    Saubermann, Lawrence
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S455 - S456
  • [48] Genetic Associations with Adverse Events from Anti-TNF Therapy in IBD Patients
    Lew, Daniel
    Yoon, Soon Man
    Yan, Xiaofei
    Robbins, Lori
    Haritunians, Talin
    Li, Dalin
    McGovern, Dermot
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S271 - S272
  • [49] Anti-TNF Therapy in Patients with HIV Infection
    Marco, Joanna
    Bays, Alison
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [50] Paradoxical inflammation induced by anti-TNF agents in patients with IBD
    Isabelle Cleynen
    Séverine Vermeire
    Nature Reviews Gastroenterology & Hepatology, 2012, 9 : 496 - 503
12345